|Bid||0.00 x 900|
|Ask||163.00 x 800|
|Day's Range||130.08 - 144.80|
|52 Week Range||55.90 - 181.07|
|Beta (5Y Monthly)||0.50|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
What happened Shares of Guardant Health (NASDAQ: GH) were sinking 7.9% as of 3:05 p.m. EST on Thursday. The genomics company didn't report any news that would cause its stock to slide. Instead, Guardant Health's shares were pulled down by the broader market sell-off.
A picks-and-shovels precision medicine play that doesn't tend to grab headlines, CareDx (NASDAQ: CDNA) describes itself as "focused on better outcomes through personalized transplant surveillance." Its suite of offerings encompasses the spectrum of transplant medicine: waitlist management for patients, high-resolution donor matching, AI analysis for risk of transplant rejection, and diagnostic blood and urine testing for transplant failure and/or rejection. Investors intrigued by larger peers such as Guardant Health (NASDAQ: GH) may want to consider CareDx as a better healthcare bargain at a fraction of the price.
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today